Read the following excerpt from Biospecific's last quarterly report:

"As of the date of this quarterly report, we have limited cash resources available to fund our operations. If we are unable to obtain funding in the next few months, our cash reserves will be depleted, and we may have to cease operations or explore available alternatives."

Biospecifics (BSTC) expects operating losses to continue while they attempt to get their upgraded manufacturing facility in Curacao approved by the U.S. Food and Drug Administration ("FDA"). Without an FDA approved facility, BSTC cannot produce collagenase for use in the United States and thereby cannot generate much needed revenue.

It appears that Biospecifics does not have the capital or funding to survive, and thus the potential demise of Phase III DP collagenase trials. Does anyone have further information regarding what appears to be a rather bleak outlook for BSTC and the Phase III trails?

Mike

Jim
I was most distressed to learn about the possibility of BST's possible demise.

Everything seems to point toward the very necessity of everyone getting together and organizing a movement to require the FDA to research and fund NA in this country.
Anyone have ideas on how we could go about this as a group?

I'm listening...... thanks, Miriam

Interesting...maybe we all need to start writing letters.
This hope of collagenase injections has been going on for too many years. NA should be performed in the US. Otherwise, we go to Europe. Hopefully, soon it will be available in Montreal. In the meantime, learn all you can to make your liver healthy.